Access cutting-edge heart disease treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access heart disease specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart disease treatment provided free
V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. Inclisiran is a subcutaneous, twice-yearly injection that is FDA-approved as an adjunct with statin therapy and on the market to lower LDL-C in high-risk populations.
Sponsor: Duke University
Check if you qualify for this heart disease clinical trial in Little Rock, AR
If you're searching for heart disease treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.